Cure8 research brief
Why This Matters
Asymptomatic C. difficile colonization is common in IBD and can be hard to distinguish from disease activity. A reliable screening method during routine colonoscopy could help researchers and clinicians study how often colonization occurs and whether it affects IBD outcomes or infection risk.
Who Should Pay Attention
Adult IBD patients (Crohn's and ulcerative colitis), gastroenterologists/endoscopists, clinical microbiologists, and researchers studying C. difficile and the gut microbiome in IBD.
Study Snapshot
What To Know
Researchers tested whether colonic wash aspirates collected during routine colonoscopy can detect asymptomatic Clostridioides difficile colonization in people with Crohn's disease or ulcerative colitis.
They cultured wash samples, used enrichment to improve detection, confirmed isolates by MALDI-TOF and PCR for the tcdB toxin gene, and performed whole-genome sequencing on selected isolates. In a cohort of 121 outpatient IBD patients, 10.7% were colonized; colonization was more common in Crohn's than ulcerative colitis.
About half of colonized patients carried C. difficile with the tcdB gene. Enrichment culture detected more carriers than direct plating, and wash samples provided sufficient DNA for sequencing comparable to stool. The authors conclude that colonoscopy wash aspirates are a feasible way to screen for asymptomatic C.
difficile colonization and could be useful for studying prevalence, persistence, and clinical implications in IBD. This summary is based on the article abstract provided by the journal; Cure8 did not review the full paper beyond the supplied abstract.
Keep In Mind
Structured content depth: abstract — the brief is grounded in the article abstract provided by the journal. The study reports detection and methods but does not establish clinical outcomes or management changes from colonization alone.
Source Details
Review the original publication for the complete reporting, methods, and context.
Funding disclosed by the source: Hatch Family Fund; Massachusetts Life Sciences Center; National Institutes of Health - R01 AI179807; National Institutes of Health - Harvard Digestive Diseases Center grant P30 DK034854
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.